"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about COUMADIN
• Ask Community about COUMADIN
• COUMADIN Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

COUMADIN Safety Questions, COUMADIN Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about COUMADIN. Our extensive database of COUMADIN adverse events and COUMADIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about COUMADIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

COUMADIN Safety Reports

Total COUMADIN reports: 784.
COUMADIN FDA safety alerts: 2002 2005 2006 2007 .
Reported deaths: 105    Reported hospitalizations: 270.
Take COUMADIN Side Effects Survey or Share Your COUMADIN Story. COUMADIN Usage.

Showing 1-75 of 784 Next >

Health Professional from FRANCE reported COUMADIN problem on Feb 28, 2007. Female patient, 47 years of age, weighting 138.9 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: lymphopenia, necrosis, vascular purpura. COUMADIN dosage: unknown. During the same period patient was treated with PREVISCAN. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Health Professional from FRANCE on Feb 28, 2007. Male patient, 56 years of age, was diagnosed with prophylaxis, pulmonary tuberculosis, sleep disorder and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: porphyria. COUMADIN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, DEXAMBUTOL, ZOLPIDEM TARTRATE, RIFATER. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on Mar 02, 2007. Male patient, 89 years of age, weighting 126.3 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, chest pain, diarrhoea, dyspnoea, gastrointestinal haemorrhage, international normalised ratio increased, prothrombin time prolonged, pyrexia. COUMADIN dosage: 1 MG ON EVEN DAYS, 2MG ODD DAYS DAILY PO. During the same period patient was treated with PLAVIX, ZANTAC, SINGULAIR, SEREVENT, LISINOPRIL, METOPROLOL SUCCINATE, ASPIRIN, PREDNISONE. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Pharmacist from UNITED STATES on Mar 02, 2007. Male patient, 69 years of age, weighting 178.6 lb, was diagnosed with pulmonary embolism and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haematoma, international normalised ratio increased, prothrombin time prolonged. COUMADIN dosage: 5MG DAILY PO. During the same period patient was treated with PREDNISONE, NORVASC, HYDROCHLOROTHIAZIDE, BENICAR, ADVAIR DISKUS, PROZAC, PROTONIX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 02, 2007. Female patient, 70 years of age, weighting 132.3 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: chromosome abnormality, platelet disorder. COUMADIN dosage: unknown. During the same period patient was treated with FIORINAL, ASPIRIN. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 23, 2007. Female patient, 52 years of age, weighting 220.0 lb, was diagnosed with thrombosis prophylaxis, gout and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal wall infection, abscess, adhesiolysis, alveoloplasty, back pain, bacterial infection, bone disorder, bone neoplasm malignant, cardiac failure congestive. COUMADIN dosage: 7.5 MG, QD. During the same period patient was treated with ALLOPURINOL, POTASSIUM ACETATE, PROTONIX, ALDACTONE, ALPRAZOLAM, FERROUS SULPHATE, INTERFERON. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on Mar 06, 2007. Female patient, 82 years of age, weighting 228.0 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: blister, contusion, haemorrhagic anaemia, hypotension, limb injury, necrosis, pain in extremity. COUMADIN dosage: 10MG PO DAILY. During the same period patient was treated with LOVENOX, LISINOPRIL, LOMOTIL, SYNTHROID, LASIX, ATENOLOL, ATIVAN, CYMBALTA. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Health Professional from UNITED STATES on Mar 06, 2007. Male patient, 86 years of age, weighting 222.7 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: hospitalisation. COUMADIN dosage: unknown. During the same period patient was treated with CANGRELOR, CLOPIDOGREL BISULPHATE, LOVENOX. Patient was hospitalized. Patient recovered.

Health Professional from ITALY reported COUMADIN problem on Mar 08, 2007. Male patient, 86 years of age, was diagnosed with arrhythmia and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: bladder diverticulum, blood pressure increased, haematuria, international normalised ratio increased, nephrolithiasis, neuropathy peripheral, renal cyst. COUMADIN dosage: unknown. Patient recovered.

COUMADIN problem was reported by a Physician from UNITED STATES on Mar 07, 2007. Male patient, 88 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, pneumonia aspiration. COUMADIN dosage: unknown. Patient died on 10/10/2006.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 14, 2007. Male patient, 85 years of age, weighting 149.9 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: dizziness, fall, gait disturbance, injury, international normalised ratio fluctuation, stomach discomfort. COUMADIN dosage: 2.5MG/D ALTERNATING WITH 5MG/D. During the same period patient was treated with NIFEDIPINE, ATENOLOL, DIOVAN, PROSCAR, HYTRIN, CLONAZEPAM, MYSOLINE. Patient recovered.

COUMADIN problem was reported by a Physician from UNITED STATES on Mar 14, 2007. Male patient was diagnosed with cardiac valve disease and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cardiac valve disease, coronary artery disease. COUMADIN dosage: ALTERNATING DOSES 2MG AND 5MG. Patient died.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 15, 2007. Male patient, 85 years of age, weighting 149.9 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: dizziness, fall, international normalised ratio fluctuation, stomach discomfort. COUMADIN dosage: 2.5MG/D ALTERNATING WITH 5MG/D. During the same period patient was treated with NIFEDIPINE, ATENOLOL, DIOVAN, PROSCAR, HYTRIN, CLONAZEPAM, MYSOLINE. Patient recovered.

COUMADIN problem was reported by a Health Professional from UNITED STATES on Mar 19, 2007. Female patient, child 10 years of age, was diagnosed with anaemia, respiratory failure and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: pneumonia, renal failure. COUMADIN dosage: unknown. During the same period patient was treated with PROCRIT, OXYGEN, INSULIN. Patient was hospitalized. Patient died on 01/23/2007.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 20, 2007. Male patient, 76 years of age, weighting 180.8 lb, was diagnosed with atrial fibrillation, musculoskeletal pain and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, chronic obstructive pulmonary disease. COUMADIN dosage: unknown. During the same period patient was treated with COLCHICINE, LIPITOR, LASIX, HYDROCHLOROTHIAZIDE, SPIRIVA, LORTAB, PREDNISONE, ALBUTEROL. Patient was hospitalized. Patient died on 03/14/2007.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2007. Male patient, 58 years of age, was treated with COUMADIN. COUMADIN dosage: unknown. Patient died.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 12, 2007. Female patient was diagnosed with insomnia and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: confusional state, fall, haemorrhage intracranial, sleep walking. COUMADIN dosage: unknown. During the same period patient was treated with AMBIEN. Patient died on 02/23/2006.

COUMADIN problem was reported by a Health Professional from UNITED STATES on Mar 21, 2007. Female patient, 66 years of age, weighting 154.0 lb, was diagnosed with hypercoagulation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. COUMADIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on Mar 22, 2007. Female patient, 73 years of age, weighting 129.2 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, fall, haemorrhage, international normalised ratio increased, mouth injury. COUMADIN dosage: 5 MG DAILY PO. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Health Professional from FRANCE on Mar 22, 2007. Male patient, 84 years of age, was diagnosed with embolism, thrombosis, epilepsy and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: epistaxis. COUMADIN dosage: unknown. During the same period patient was treated with KARDEGIC, SEROPRAM, NEURONTIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 22, 2007. Male patient, 83 years of age, weighting 262.4 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased, thrombosis, transient ischaemic attack. COUMADIN dosage: 11-06-02-07 DOSE=1MGX4D/WK .5 MGX3D/WK 02-07 6 MG/WK INCREASED 03-15-07 7MG/WK 03-22-07 8.5 MG/WK. During the same period patient was treated with PLAVIX, DIGITEK, VYTORIN, SYNTHROID, TYLENOL, TRIAMTERENE, AVODART, TOPROL. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2007. Female patient, 80 years of age, weighting 163.1 lb, was diagnosed with arrhythmia and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: burning sensation, epistaxis, insomnia, oedema peripheral, pain in extremity. COUMADIN dosage: 4 MG TAB 3 TIMES/WK AND 2 MG REMAINING DAYS; THEN 4 MG TWICE/WK AND 2 MG REMAINING DAYS. During the same period patient was treated with PLAVIX, TOPROL, ASPIRIN, TYLENOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Mar 27, 2007. Male patient, weighting 253.5 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, coagulopathy, deep vein thrombosis, pulmonary embolism. COUMADIN dosage: unknown. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2007. Male patient, 74 years of age, weighting 189.6 lb, was diagnosed with cardiac disorder and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: bronchitis, haemoptysis. COUMADIN dosage: unknown. During the same period patient was treated with FUROSEMIDE, METOPROLOL SUCCINATE, FINASTERIDE, SIMVASTATIN, TAMSULOSIN, ASPIRIN, POTASSIUM CHLORIDE, COMBIVENT. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported COUMADIN problem on Apr 05, 2007. Female patient, 42 years of age, weighting 134.5 lb, was diagnosed with deep vein thrombosis, breast cancer metastatic and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: epistaxis, international normalised ratio increased, prothrombin time prolonged, sinusitis. COUMADIN dosage: unknown. During the same period patient was treated with LAPATINIB, CAPECITABINE. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient, weighting 143.3 lb, was diagnosed with transient ischaemic attack and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, flatulence, transient ischaemic attack. COUMADIN dosage: unknown. During the same period patient was treated with DYAZIDE, TENORMIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on Apr 05, 2007. Male patient, 81 years of age, weighting 191.0 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: aspiration, cerebral haemorrhage, headache, hypoxia, nausea, vomiting. COUMADIN dosage: 1.5MG AS DIRECTED ORALLY. During the same period patient was treated with CYANOCOBALAMIN, LISINOPRIL, OMEPRAZOLE, SIMVASTATIN. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Male patient, 83 years of age, was diagnosed with osteoporosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: arrhythmia, asthenia, cholelithiasis, gait disturbance, gallbladder disorder, jaundice. COUMADIN dosage: 5 MG, DAILY (1/D) MONDAY THROUGH FRIDAY. During the same period patient was treated with FORTEO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Apr 10, 2007. Female patient, weighting 138.9 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased, lymphoma. COUMADIN dosage: unknown. During the same period patient was treated with LISINOPRIL, CARDIZEM, DIGITEK, LEXAPRO, ASCORBIC ACID, CALCIUM LACTATE, CANSTAT, PROTEASE. Patient recovered.

COUMADIN problem was reported by a Health Professional from UNITED STATES on Apr 10, 2007. Male patient, weighting 235.0 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, international normalised ratio decreased. COUMADIN dosage: 5 MG ONCE A DAY PO. Patient died on 03/17/2007.

Health Professional from FRANCE reported COUMADIN problem on Apr 16, 2007. Female patient, 55 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage. COUMADIN dosage: unknown. During the same period patient was treated with AVASTIN, CAMPTOSAR, FLUOROURACIL, ZOPHREN. Patient died on 01/25/2007.

COUMADIN problem was reported by a Health Professional from FRANCE on Apr 16, 2007. Female patient, 81 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. COUMADIN dosage: unknown. During the same period patient was treated with OMEPRAZOLE, INNOHEP, ACETAMINOPHEN AND TRAMADOL, LOVENOX, ORGARAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Apr 13, 2007. Female patient, 78 years of age, weighting 134.5 lb, was diagnosed with transient ischaemic attack and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, international normalised ratio decreased, skin discolouration, transient ischaemic attack. COUMADIN dosage: unknown. During the same period patient was treated with PLAVIX, ASPIRIN, PROGESTERONE, ESTRADERM, DIGOXIN. Patient recovered.

COUMADIN problem was reported by a Pharmacist from UNITED STATES on Apr 19, 2007. Male patient, 78 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, post procedural haemorrhage, ventricular arrhythmia. COUMADIN dosage: unknown. During the same period patient was treated with LOVENOX. Patient died.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Apr 18, 2007. Female patient, 78 years of age, weighting 134.5 lb, was diagnosed with transient ischaemic attack and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, international normalised ratio decreased, skin discolouration, transient ischaemic attack. COUMADIN dosage: unknown. During the same period patient was treated with PLAVIX, ASPIRIN, PROGESTERONE, ESTRADERM, DIGOXIN. Patient recovered.

COUMADIN problem was reported by a Pharmacist from UNITED STATES on Apr 20, 2007. Male patient, 73 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal haematoma, confusional state, haematocrit decreased, haemoglobin decreased, retroperitoneal haemorrhage. COUMADIN dosage: unknown. During the same period patient was treated with LOVENOX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on Apr 20, 2007. Female patient, 22 years of age, weighting 127.9 lb, was diagnosed with pulmonary embolism and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: dehydration, dyspnoea, haemoptysis, international normalised ratio decreased, nausea, vomiting. COUMADIN dosage: unknown. During the same period patient was treated with HEPARIN, LOVENOX, PEPCID, FOLIC ACID, PHENERGAN, DILAUDID. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Physician from FRANCE on Apr 17, 2007. Female patient, weighting 130.1 lb, was diagnosed with ill-defined disorder, hypertension and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: confusional state. COUMADIN dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE. Patient recovered.

Health Professional from FRANCE reported COUMADIN problem on Apr 23, 2007. Male patient, 63 years of age, weighting 198.4 lb, was diagnosed with pulmonary embolism, phlebitis, hypercholesterolaemia, gastric ulcer, hypertension and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage intracranial, road traffic accident. COUMADIN dosage: unknown. During the same period patient was treated with ALLOPURINOL, FENOFIBRATE, NEXIUM, INDAPAMIDE, CALDINE. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 25, 2007. Male patient, weighting 132.3 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. COUMADIN dosage: unknown. Patient was hospitalized and became disabled. Patient died.

Pharmacist from UNITED STATES reported COUMADIN problem on Apr 25, 2007. Female patient was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased. COUMADIN dosage: 10MG DAILY PO. Patient recovered.

COUMADIN problem was reported by a Health Professional from FRANCE on Apr 25, 2007. Female patient, 65 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: gastric ulcer haemorrhage, international normalised ratio increased. COUMADIN dosage: unknown. During the same period patient was treated with PERISTALTINE, FORLAX, CONTRAMAL, TRACLEER, PARACETAMOL, DIFFU, INIPOMP, LOVENOX. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on Apr 26, 2007. Female patient, 91 years of age, weighting 75.18 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haematoma. COUMADIN dosage: 1 MG DAILY PO. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 27, 2007. Male patient, 81 years of age, weighting 240.3 lb, was diagnosed with thrombosis prophylaxis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: anuria, asthenia, contusion, thrombosis, vision blurred. COUMADIN dosage: unknown. During the same period patient was treated with AMIODARONE, DIGITALIS, OCUVITE, LIPITOR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on May 01, 2007. Male patient, 75 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: fall, international normalised ratio fluctuation. COUMADIN dosage: unknown. During the same period patient was treated with DILTIAZEM, ZETIA, TEMODAR, PROTONIX, MUCOMYST, LEVEMIR, KEPPRA, DILANTIN. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Pharmacist from UNITED STATES on May 02, 2007. Female patient, weighting 221.6 lb, was diagnosed with atrial fibrillation, cellulitis, staphylococcal infection and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased, small intestinal haemorrhage, vomiting. COUMADIN dosage: unknown. During the same period patient was treated with BACTRIM DS, BACTRIM DS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported COUMADIN problem on May 03, 2007. Female patient, 87 years of age, weighting 118.0 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: coagulopathy, ecchymosis, epistaxis, haematochezia, haemoptysis, haemorrhage. COUMADIN dosage: 7 MG 3 X A WEEK PO. During the same period patient was treated with GINGER. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Male patient, 42 years of age, weighting 253.5 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, coagulopathy, deep vein thrombosis, pulmonary embolism. COUMADIN dosage: DOSE 20MG 31MAR07, ALSO GIVEN 60 MG 28MAR07, 30MG 1APR07, 50MG 3APR-5APR07. During the same period patient was treated with ADVAIR DISKUS, ALBUTEROL, ASPIRIN, DIAZEPAM, METOPROLOL SUCCINATE, ATORVASTATIN CALCIUM, MEPERIDINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on May 08, 2007. Female patient, weighting 119.0 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, cerebral atrophy. COUMADIN dosage: unknown. During the same period patient was treated with LOVASTATIN, METOPROLOL SUCCINATE, HYZAAR, DIGITEK, POTASSIUM ACETATE, OMEPRAZOLE, PREMARIN. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Male patient, 92 years of age, was diagnosed with ejection fraction decreased, discomfort and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cardiac output decreased, cardiogenic shock. COUMADIN dosage: WARFARIN 1MG ALSO MENTIONED. During the same period patient was treated with MORPHINE, PHENERGAN, ATIVAN. Patient died on 12/13/2006.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on May 08, 2007. Male patient, 92 years of age, was diagnosed with ejection fraction decreased, discomfort and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cardiac output decreased, cardiogenic shock. COUMADIN dosage: WARFARIN 1MG ALSO MENTIONED. During the same period patient was treated with MORPHINE, PHENERGAN, ATIVAN. Patient died on 12/13/2006.

COUMADIN problem was reported by a Health Professional from FRANCE on May 09, 2007. Female patient, 62 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: bradycardia, subdural haematoma. COUMADIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on May 16, 2007. Female patient, 80 years of age, weighting 169.8 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, rectal haemorrhage. COUMADIN dosage: unknown. During the same period patient was treated with NORVASC, ZANTAC, TRAMADOL, GLUCOSAMINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Pharmacist from UNITED STATES on May 16, 2007. Male patient, 76 years of age, weighting 238.1 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: arteriovenous malformation, asthenia, colonic polyp, dyspnoea, haematocrit decreased, haemoglobin decreased, hypotension, international normalised ratio increased, occult blood positive. COUMADIN dosage: unknown. During the same period patient was treated with TOPROL, ASPIRIN, FUROSEMIDE, POTASSIUM CHLORIDE, DILTIAZEM CD, GLIPIZIDE, LISINOPRIL, LIPITOR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on May 08, 2007. Female patient, 80 years of age, weighting 127.0 lb, was diagnosed with osteoporosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: balance disorder, fall, injury, subdural haematoma. COUMADIN dosage: unknown. During the same period patient was treated with LOVASTATIN, SYNTHROID, FORTEO. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2007. Female patient, 87 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, atrial fibrillation, dementia alzheimer's type, vaginal haemorrhage. COUMADIN dosage: unknown. Patient died on 05/05/2007.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on May 18, 2007. Female patient, 87 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, atrial fibrillation, dementia alzheimer's type, vaginal haemorrhage. COUMADIN dosage: unknown. Patient died on 05/05/2007.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Male patient, 68 years of age, was diagnosed with myocardial infarction, thrombosis and was treated with COUMADIN. COUMADIN dosage: unknown. Patient died on 10/31/1987.

Pharmacist from FRANCE reported COUMADIN problem on May 25, 2007. Female patient, 60 years of age, was diagnosed with factor v leiden mutation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, arterial thrombosis, colitis ischaemic, diarrhoea. COUMADIN dosage: unknown. During the same period patient was treated with KARDEGIC. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, weighting 169.8 lb, was treated with COUMADIN. COUMADIN dosage: unknown. During the same period patient was treated with NEURONTIN, EFFEXOR, CRESTOR, XOPENEX. Patient died on 05/25/2007.

Health Professional from FRANCE reported COUMADIN problem on May 28, 2007. Male patient, 81 years of age, weighting 167.6 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haematoma, lung disorder, neurological symptom. COUMADIN dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, MORPHINE CHLORIDE, RYTHMOL, DILTIAZEM, URAPIDIL. Patient died on 02/09/2007.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Male patient, 74 years of age, weighting 189.6 lb, was diagnosed with cardiac disorder and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: bronchitis, haemoptysis. COUMADIN dosage: unknown. During the same period patient was treated with FUROSEMIDE, METOPROLOL SUCCINATE, FINASTERIDE, SIMVASTATIN, TAMSULOSIN, ASPIRIN, POTASSIUM CHLORIDE, COMBIVENT. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported COUMADIN problem on May 31, 2007. Male patient, 78 years of age, was diagnosed with multiple myeloma and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: dehydration, gastrointestinal haemorrhage, prothrombin time prolonged, respiratory distress. COUMADIN dosage: unknown. During the same period patient was treated with REVLIMID. Patient was hospitalized. Patient died on 04/02/2007.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Female patient, 66 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: foaming at mouth, loss of consciousness. COUMADIN dosage: unknown. During the same period patient was treated with PLAVIX, ASPIRIN, COREG. Patient died on 04/21/2007.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on June 01, 2007. Female patient, 74 years of age, weighting 138.9 lb, was diagnosed with atrial fibrillation and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased, lymphoma. COUMADIN dosage: unknown. During the same period patient was treated with LISINOPRIL, CARDIZEM, DIGITEK, LEXAPRO, ASCORBIC ACID, CALCIUM LACTATE, CANSTAT, PROTEASE. Patient recovered.

COUMADIN problem was reported by a Physician from FRANCE on June 11, 2007. Female patient, 81 years of age, was diagnosed with tuberculosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: biliary tract infection, dementia, hepatitis toxic, international normalised ratio increased, intervertebral discitis, lung disorder, overdose, peritonitis. COUMADIN dosage: unknown. During the same period patient was treated with RIFADIN, OFLOCET. Patient was hospitalized. Patient died.

Physician from FRANCE reported COUMADIN problem on June 11, 2007. Male patient, 95 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: coagulopathy, erysipelas. COUMADIN dosage: unknown. During the same period patient was treated with DOLIPRANE, PYOSTACINE, BURINEX, XATRAL, HEMIGOXINE NATIVELLE, CARBOSYLANE, METFORMIN. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Physician from FRANCE on June 11, 2007. Female patient, 84 years of age, weighting 79.37 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, pancreatic enzymes increased. COUMADIN dosage: unknown. During the same period patient was treated with LORAZEPAM, ATHYMIL, AMLOR, LAMICTAL, TAHOR, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported COUMADIN problem on June 15, 2007. Male patient, 58 years of age, weighting 250.0 lb, was diagnosed with deep vein thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: ecchymosis, extremity necrosis, pain in extremity. COUMADIN dosage: 5MG PO DAILY. During the same period patient was treated with LOPRESSOR, CRESTOR, ASPIRIN, PLAVIX, LORTAB. Patient recovered.

COUMADIN problem was reported by a Physician from ITALY on June 19, 2007. Female patient, 71 years of age, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: renal failure, shock, stomatitis. COUMADIN dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported COUMADIN problem on June 19, 2007. Female patient, 84 years of age, weighting 79.37 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. COUMADIN dosage: unknown. During the same period patient was treated with LORAZEPAM, ATHYMIL, AMLOR, LAMICTAL, TAHOR, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 18, 2007. Female patient, 64 years of age, weighting 220.0 lb, was diagnosed with deep vein thrombosis, pulmonary thrombosis and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage, incorrect dose administered, skin laceration. COUMADIN dosage: unknown. During the same period patient was treated with LOVENOX, ENTERIC ASPIRIN. Patient died on 06/06/2007.

Physician from UNITED STATES reported COUMADIN problem on June 08, 2007. Male patient, 40 years of age, was diagnosed with vascular bypass graft, multiple congenital abnormalities and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease. COUMADIN dosage: unknown. During the same period patient was treated with PLAVIX. Patient recovered.

COUMADIN problem was reported by a Physician from ITALY on June 19, 2007. Female patient, 71 years of age, was diagnosed with atrial fibrillation, hyperuricaemia and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: renal failure, shock, stomatitis. COUMADIN dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported COUMADIN problem on June 18, 2007. Female patient, 52 years of age, weighting 220.0 lb, was diagnosed with thrombosis prophylaxis, gout and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: abscess, adhesiolysis, alveoloplasty, back pain, bacterial infection, bone disorder, bone neoplasm malignant, cardiac failure congestive, depressed level of consciousness. COUMADIN dosage: 7.5 MG, QD. During the same period patient was treated with ALLOPURINOL, POTASSIUM ACETATE, PROTONIX, ALDACTONE, ALPRAZOLAM, FERROUS SULPHATE, INTERFERON. Patient was hospitalized. Patient recovered.

Showing 1-75 of 784 Next >

Ask Our Patient Community about COUMADIN
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin)